what is success rate for bcg treatment for bladder cancer


This method of treatment is considered a form of immunotherapy, which is an emerging form of cancer treatment. The success rate for BCG treatment for bladder cancer is about 90%, which is considered the best life-saving rate by any treatment.Dec 20, 2021

What are the chances of bladder cancer returning after BCG treatment?

“Initially, it’s effective,” says medical oncologist Noah Hahn, M.D. However, adds urologist Max Kates, M.D., “while up to 35 percent of patients have long-term, sustained remissions with intravesical BCG, as many as 60 percent of patients will have a recurrence of cancer within two years.

Can BCG cure bladder cancer?

BCG is type of immunotherapy for bladder cancer. Doctors typically use BCG to prevent cancer returning following TURBT in people with early-stage disease. BCG is not effective against bladder cancer that has spread to other parts of the body.

How often does BCG fail?

Evidence synthesis: Overall, the failure rate in response to BCG is about 40-50%. Most guidelines recommend that patients failing BCG should be offered radical cystectomy (RC).

When does BCG treatment fail?

BCG refractory is when there is failure to achieve a disease-free state within 6 months after initial BCG, with either maintenance or re-treatment at 3 months because of either persistent or rapidly recurrent disease.

What happens if BCG treatments don’t work?

BCG failure usually carries a risk of recurrence but rarely of progression. For low-grade failure, intravesical chemotherapy is a valid option. This scenario is different from that where BCG intravesical therapy is unsuccessful in high-risk T1 disease and/or CIS, where a risk of progression may sometimes reach 50%.

What are the long term side effects of BCG treatment for bladder cancer?

These adverse effects include fever, malaise, and bladder irritation (urination frequency, dysuria, or mild hematuria). Fever indicates adequate immune activation and is associated with a more favorable antitumor response (25). Skin rash and arthralgia are possible allergic reactions (26,27).

How long does BCG bladder treatment stay in your system?

BCG is given directly into the bladder (called intravesicular) through a catheter. The medicine is left in the bladder for 1-2 hours. The dosage and schedule is determined by your healthcare provider. It is not uncommon to have urinary frequency (need to go often) or painful urination for 48 hours after treatment.

Can BCG treatment be repeated?

In patients who develop a CIS recurrence after a single prior BCG failure, repeat BCG-based therapy should be administered. Repeat BCG monotherapy has demonstrated a 2-year disease-free rate of 30–42% in two small studies [2, 59].

Is there an alternative to BCG?

If BCG is not available, alternatives to BCG such as gemcitabine, epirubicin, docetaxel, valrubicin, mitomycin, or sequential gemcitabine/docetaxel or gemcitabine/mitomycin may also be considered with an induction and possible maintenance regimen.

Is BCG considered immunotherapy?

BCG treatment is the main immunotherapy used to treat early-stage bladder cancer.

What are the side effects of BCG treatment?

Common side effects of BCG include needing to urinate more often; burning or pain when urinating; blood in the urine; a mild fever; and tiredness. These side effects usually last a couple of days after each BCG treatment session. Less often, the BCG may spread through the body and can affect any organ.

Is BCG a chemo drug?

Some people may know BCG as a vaccine used to prevent tuberculosis (TB). But it is also a main treatment for non-muscle-invasive bladder cancer. BCG is a type of immunotherapy drug. Immunotherapy drugs encourage the body’s immune system to fight cancer cells.

Categories FAQ

Leave a Comment